Close Menu

hepatitis

The firm noted that the premarket approval means that the three major viral load assays that most laboratories run for patients are now available on a single system.

While the virus they found appears old, the researchers found it to be closely related to modern ones, indicating that it has infected people for centuries.

The test is performed on the company's AmpiProbe platform, and the approval expands Enzo's offering of infectious disease tests in New York.

Medcis Pathlabs and its associates and attendees will buy Co-Diagnostics' tests for hepatitis B, hepatitis C, HIV, and human papillomavirus.

The test adds to the firm's current portfolio of 30 infectious disease and oncology tests that use its Sentosa PCR and NGS workflow.

Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now.

The test enables donor screening laboratories to use PCR-based diagnostic technology to screen donated blood and plasma.

Professional, molecular, and tissue diagnostics sales continued to grow during the first three quarters, while diabetes care sales remained in decline.

This Week in Nature

In Nature this week: modified CRISPR approach changes single nucleotides, new salmon genome assembly, and more.

Roche's molecular diagnostics business, which makes up 17 percent of its overall diagnostics sales, grew 11 percent, driven by virology testing and sequencing.

Pages

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.